PEMT and metabolic dysfunction-associated steatohepatitis: A previous study reported that the variant Val175Met of the PEMT gene could be a prognostic biomarker for susceptibility to NASH, as this genetic variant was more frequently demonstrated in lean NASH patients [59] (Figure 1).